G-Protein Coupled Receptor (GPCR) Targeting: Technologies and Global Markets

Report Highlights

The global G protein, coupled receptors (GPCR) targeting drug market sharply fell in the last three years due to a series of patent expirations of blockbuster products. The market receded from nearly $111 billion to almost $100 billion with a -3.4% compound annual growth rate (CAGR) between 2010 and 2013. With the introduction of novel pharmacecuticals and newly appearing classes of drugs, BCC Research expects this market to reach $114 billion by 2018, a CAGR of 2.7% from 2013 to 2018.

Report Includes

• An overview of the global market for G-protein coupled ceceptor (GPCR) targeting and related technologies.
• Analyses of global market trends, with data from 2010, 2011, 2012, 2013 and projections of compound annual growth rates (CAGRs) through 2018.
• A breakdown of the market into the regions the U.S; Europe; Japan; Brazil, Russia, India, China (BRIC), and the rest of the world.
• Relevant patent anlaysis.
• Comprehensive profiles of major companies in the industry.

Report Scope

The scope of this study encompasses the GPCR targeting drugs in pharmaceutical and biopharmaceutical markets. BCC Research analyzed each market and its applications, regulatory environment, technology, market projections and market share. Technological issues include the latest trends and developments. The strong growing market for the GPCR drugs includes the countries of the EU such as the U.K., France, Germany, Spain and Italy, and also include the emerging countries such as China, Brazil, South Korea, Taiwan, Mexico and other countries.

Analyst Credentials

Ufuk Ezer. Ezer holds a bachelor's degree in bioengineering and a master's degree in biotechnology, bioprocessing and business management. He possesses extensive pharmaceutical research and development experience and has participated in projects for various international institutions and organizations. Ezer has been granted scholarships and awards during his post-study works in countries such as Japan and Panama based on the high quality of his work and excellence in the fields of research.